Success! Publication Hasn’t Been Rejected Within First Four Minutes Of Submission

Crooks, T. et al.

After months of writing, post-doc Dr. Richard Warton submitted a manuscript to a publisher at 11:59am and was shocked to discover that, just four minutes later, it had not yet been rejected.

“It’s been a stressful past 240 seconds,” Warton explains, “but I think this is a good sign since it hasn’t been turned down yet! I just hope they don’t read too much into those discussion comments.” 

Upon reflection, Warton grew increasingly concerned regarding a few of his figures just before the submission deadline. Figure 2 was really meant to help broaden the scope of the study, yet he cannot help but feel that it may in fact be considered a weakness. “Oh shit,” said Warton, “what if we should have included that 3rd control for clarity?! Oh shit. Oh shit.”

As the clock struck 12:04 AM, Warton began drafting apology emails to his collaborators to illustrate why it’s really the journal’s fault in the first place. “They probably picked really horrible reviewers too. It’s honestly a rigged system.”

In an unexpected turn of events, at 12:05 AM, Warton noticed a new email in his inbox. A sense of panic ran through him. 

“Fortunately, it was only a student asking for an extension since she just got hit by a bus,” said a relieved Warton. “Thankfully everything is still fine!”

Get access to more dnatured

Support Taylor Crooks on Patreon and get more dnatured perks starting from just $1.00

About Author

Taylor Crooks

Taylor is a post-baccalaureate researcher at Mayo Clinic in Minnesota studying the microbiome and its impact on ovarian and endometrial cancer. In addition, Taylor is also studying secondary bile acids as tumor growth inhibitors in ovarian cancer.

About Taylor Crooks 1 Article
Taylor is a post-baccalaureate researcher at Mayo Clinic in Minnesota studying the microbiome and its impact on ovarian and endometrial cancer. In addition, Taylor is also studying secondary bile acids as tumor growth inhibitors in ovarian cancer.